Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
EYEPOINT PHARMACEUTICALS, INC. (EYPT) had Return on Equity of -38.89% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$43.27M |
|
$-130.87M |
|
$3.71M |
|
$39.56M |
|
$189.13M |
|
$-145.85M |
|
$15.07M |
|
$-130.78M |
|
$-130.78M |
|
$-130.87M |
|
$-130.87M |
|
$-130.87M |
|
$-130.87M |
|
$-145.85M |
|
$-150.27M |
|
56.30M |
|
56.30M |
|
$-2.32 |
|
$-2.32 |
|
| Balance Sheet Financials | |
$383.31M |
|
$8.18M |
|
$35.16M |
|
$418.46M |
|
$49.05M |
|
-- |
|
$32.92M |
|
$81.96M |
|
$336.50M |
|
$336.50M |
|
$336.50M |
|
68.27M |
|
| Cash Flow Statement Financials | |
$-126.23M |
|
$-219.35M |
|
$164.02M |
|
$281.41M |
|
$99.85M |
|
$-181.56M |
|
$36.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.42% |
|
-337.06% |
|
-337.06% |
|
-347.25% |
|
-302.22% |
|
-302.43% |
|
$-130.28M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.61 |
|
71.29 |
|
5.12 |
|
|
Return on Equity |
-38.89% |
-38.89% |
|
-31.27% |
|
-38.89% |
|
$4.93 |
|
$-2.31 |
|
$-2.24 |
|